Orexigen Cleared For Wind Down After Del. Ch. 11 Confirmed
Remnants of largely sold-off biopharmaceutical firm Orexigen Therapeutics Inc. whisked through a Chapter 11 plan confirmation in Delaware on Friday, clearing the way for a wind down of the business and remaining...To view the full article, register now.
Already a subscriber? Click here to view full article